Avicanna Inc.
AVCNF
Rank in Stocks
#28739
Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and... Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and founded in 2016, is actively engaged in the research, development, and commercialization of scientifically validated products for both global medical and consumer health markets. The company's comprehensive scientific framework encompasses R&D and clinical trials, often undertaken in collaboration with Canadian academic and medical institutions. This effort has yielded around twenty commercialized products spanning four primary market categories. These offerings include medical and wellness items under the RHO Phyto brand, featuring cannabinoids such as CBD, CBG, and THC; CBD-infused topical and derma-cosmetic products marketed under the Pura H&W and Pura Earth labels; and bulk cannabis and hemp-derived raw materials like dried flowers, standardized seeds, full-spectrum extracts, cannabinoid distillates, and isolates, provided through the Aureus brand. Additionally, Avicanna is advancing a pharmaceutical pipeline focused on treatments for conditions including epidermolysis bullosa, dermatological ailments, chronic pain, and various neurological disorders. A notable research partnership with Dr. Christine Allen's Research Group is dedicated to developing a cannabinoid-based therapy for lung inflammation linked to COVID-19.
Share Price
$0.07595
Last synced: 2026-11-09
Market Cap
$9.99M
Change (1 day)
1.27%
Change (1 year)
-60.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Avicanna Inc. (AVCNF)
Category
Healthcare
EPS for Avicanna Inc. (AVCNF)
EPS as of June 2026 TTM: $-0.02
According to Avicanna Inc.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Avicanna Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | 16.00% |
| 2025 | $-0.02 | -28.17% |
| 2024 | $-0.03 | -66.62% |
| 2023 | $-0.08 | -59.01% |
| 2022 | $-0.18 | -43.22% |
| 2021 | $-0.32 | -63.13% |
| 2020 | $-0.88 | 8.97% |
| 2019 | $-0.81 | 143.41% |
| 2018 | $-0.33 | 119.52% |
| 2017 | $-0.15 | 7,455.00% |
| 2016 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -28,123.28% |
DE
|
|
| $6.08 | -26,296.55% |
DE
|
|
| $1.55 | -6,783.62% |
JP
|
|
| $3.66 | -15,875.86% |
CH
|
|
| $0.45 | -2,039.66% |
IL
|
Questions about Avicanna Inc.'s earnings per share (EPS)
What is Avicanna Inc.'s earnings per share (EPS)?
Avicanna Inc.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.
What was Avicanna Inc.'s earnings per share (EPS) in 2025?
In 2025, Avicanna Inc.'s earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has Avicanna Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Avicanna Inc.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2020 ($-0.88).
How does Avicanna Inc.'s earnings per share (EPS) compare with similar companies?
Avicanna Inc.'s earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.